Search

Chinese
Resource Library / ACT 2025 Study Design Considerations for Wound Healing Research in Göttingen Minipigs

poster

ACT 2025 Study Design Considerations for Wound Healing Research in Göttingen Minipigs

Discover how Frontage’s Safety & Toxicology team optimized wound healing study design in Göttingen minipigs, offering insights that strengthen preclinical predictability and translational relevance.

Resources to Consider

Left arrow
An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide inHuman Serum and Its Application to a Clinical Study
journal

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination...
An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and A...
Access Resource
Drug-drug Interaction Study of CYP3A4 Inhibitors with Colchicine Oral Solution
journal

Drug-drug Interaction Study of CYP3A4 Inhibitors with Colchicine Oral...
The primary objective of the study was to compare the pharmacokinetic (PK) variables of pl...
Access Resource
AACR 2024: Analytical validation of a complete system for detection and characterization of genomic aberrations in circulating tumor DNA
poster

AACR 2024: Analytical validation of a complete system for detection...
Frontage Laboratories has validated a liquid biopsy NGS assay supporting Gradalis Inc.’s...
Access Resource
AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing panel for screening of ovarian cancer patients for BRCA mutations as a rerequisite for manufacturing of an autologous cellular immunotherapy
poster

AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing...
Frontage Genomics Services has validated a custom-designed 293 cancer-related genes panel....
Access Resource
General Practices for Critical Reagents Usage in Bioanalytical Labs
webinar

General Practices for Critical Reagents Usage in Bioanalytical Labs
In this webinar, Dr. Santosh Shah discusses the general industry standards for utilizing c...
Access Resource
Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing
webinar

Strategies and Solutions for Early Phase Formulation Development and...
In this webinar, we discuss the strategies to overcome challenges during formulation devel...
Access Resource
Hugh Davis for Contract Pharma
video

Hugh Davis for Contract Pharma
Check out Frontage's CBO, Hugh Davis, PhD, interview with Contract Pharma about Frontage's...
Access Resource
Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine
journal

Development and validation of LC-MS/MS methods for the quantification...
Guadecitabine (SGI-110), a dinucleotide of β‑decitabine and deoxyguanosine, is currentl...
Access Resource
Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays​
poster

Quantitative Assessment of mRNA Drug Biological Activity by...
Biological activity of mRNA drugs, historically assessed via animal study, is critical to ...
Access Resource
CMC-Product Development & Manufacturing Integrated Solutions
infographic

CMC-Product Development & Manufacturing Integrated Solutions
Frontage provides integrated solutions to our clients including Formulation, Product Devel...
Access Resource
Gut Reaction: Human Microbiome Analysis Insights
webinar

Gut Reaction: Human Microbiome Analysis Insights
The microbiome continuously shapes its environment through a complex set of interactions, ...
Access Resource
Fact Sheet: Central Lab Services
fact-sheet

Fact Sheet: Central Lab Services
At Frontage, we provide comprehensive central lab services, including a range of laborator...
Access Resource
Right arrow